This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Non-Small Cell Lung Cancer (NSCLC)
and you are
over 18
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is a randomized, open-label, multicenter, Phase 3 study, comparing efficacy and safety of eribulin with TPC in subjects with advanced and disease progression following at least two prior regimens for advanced disease, which should have included a platinum-based regimen.

Provided treatments

  • Drug: Eribulin
  • Drug: TPC -Vinorelbine,Gemcitabine,Docetaxel, and Pemetrexed

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01454934. The sponsor of the trial is Eisai Inc. and it is looking for 540 volunteers for the current phase.
Official trial title: